157 related articles for article (PubMed ID: 37009318)
1. Mitophagy-related gene signature predicts prognosis, immune infiltration and chemotherapy sensitivity in colorectal cancer.
Weng JS; Huang JP; Yu W; Xiao J; Lin F; Lin KN; Zang WD; Ye Y; Lin JP
World J Gastrointest Oncol; 2023 Mar; 15(3):546-561. PubMed ID: 37009318
[TBL] [Abstract][Full Text] [Related]
2. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
[TBL] [Abstract][Full Text] [Related]
3. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.
Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M
Front Immunol; 2022; 13():994874. PubMed ID: 36330513
[TBL] [Abstract][Full Text] [Related]
4. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer.
Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X
Front Immunol; 2022; 13():887048. PubMed ID: 35784334
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis.
Chen YF; Yu ZL; Lv MY; Cai ZR; Zou YF; Lan P; Wu XJ; Gao F
Mol Med; 2021 Oct; 27(1):139. PubMed ID: 34717544
[TBL] [Abstract][Full Text] [Related]
6. Interferon regulatory factor family influences tumor immunity and prognosis of patients with colorectal cancer.
Chen YJ; Luo SN; Dong L; Liu TT; Shen XZ; Zhang NP; Liang L
J Transl Med; 2021 Sep; 19(1):379. PubMed ID: 34488791
[TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of a Six Immune-Related Genes Signature for Predicting Prognosis in Patients With Stage II Colorectal Cancer.
Li X; Xie M; Yin S; Xiong Z; Mao C; Zhang F; Chen H; Jin L; Lan P; Lian L
Front Genet; 2021; 12():666003. PubMed ID: 34017356
[TBL] [Abstract][Full Text] [Related]
8. Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma.
Liang Z; Sun R; Tu P; Liang Y; Liang L; Liu F; Bian Y; Yin G; Zhao F; Jiang M; Gu J; Tang D
Front Immunol; 2022; 13():944286. PubMed ID: 36591255
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a circular RNA regulatory stemness-related gene pair signature for predicting prognosis and therapeutic response in colorectal cancer.
Chen Q; Tang P; Huang H; Qiu X
Front Immunol; 2022; 13():934124. PubMed ID: 35958575
[TBL] [Abstract][Full Text] [Related]
10. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of mitophagy-related signatures as a novel prognostic model for colorectal cancer.
Ke Q; Wang Y; Deng Y; Wang J; Yuan M; Liang A; Wang J; Gong Q
Transl Cancer Res; 2024 Feb; 13(2):782-797. PubMed ID: 38482399
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
13. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer.
Zheng H; Liu H; Ge Y; Wang X
Cancer Cell Int; 2021 Oct; 21(1):552. PubMed ID: 34670584
[TBL] [Abstract][Full Text] [Related]
14. A novel oxidative stress- and ferroptosis-related gene prognostic signature for distinguishing cold and hot tumors in colorectal cancer.
Wang X; Xu Y; Dai L; Yu Z; Wang M; Chan S; Sun R; Han Q; Chen J; Zuo X; Wang Z; Hu X; Yang Y; Zhao H; Hu K; Zhang H; Chen W
Front Immunol; 2022; 13():1043738. PubMed ID: 36389694
[TBL] [Abstract][Full Text] [Related]
15. A Mitophagy-Related Gene Signature for Subtype Identification and Prognosis Prediction of Hepatocellular Carcinoma.
Liu C; Wu Z; Wang L; Yang Q; Huang J; Huang J
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292980
[TBL] [Abstract][Full Text] [Related]
16. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
Front Immunol; 2022; 13():951455. PubMed ID: 36189298
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis reveals a novel 5-fluorouracil resistance-based prognostic signature with promising implications for predicting the efficacy of chemotherapy and immunotherapy in patients with colorectal cancer.
Hou Y; Zhang F; Zong J; Li T; Gan W; Lv S; Yan Z; Zeng Z; Yang L; Zhou M; Zhao W; Yang M
Apoptosis; 2024 Jun; ():. PubMed ID: 38824480
[TBL] [Abstract][Full Text] [Related]
19. Gene signatures associated with drug resistance to irinotecan and oxaliplatin predict a poor prognosis in patients with colorectal cancer.
Sun X; Wang X; Feng W; Guo H; Tang C; Lu Y; Xiang X; Bao Y
Oncol Lett; 2017 Apr; 13(4):2089-2096. PubMed ID: 28454366
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of a TNF Family-Based Signature for Predicting Prognosis, Tumor Immune Characteristics, and Immunotherapy Response in Colorectal Cancer Patients.
Xiao Z; Nie K; Han T; Cheng L; Zhang Z; Peng W; Shi D
J Immunol Res; 2021; 2021():6439975. PubMed ID: 34541005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]